Slate News What Next TBD: The Rise of Off-Brand Ozempic
Aug 18, 2024
In this insightful discussion, Kate Knibbs, a senior writer at Wired, delves into the trending world of off-brand Ozempic and weight loss medications. She highlights the alarming rise of compounding pharmacies amidst shortages. Ethical concerns around online prescriptions and the surge in telehealth companies are examined. Knibbs also sheds light on the risks tied to alternative medications, emphasizing the importance of regulatory oversight and professional consultation for safe use.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Intro
00:00 • 2min
Navigating the Risks of Compounding Pharmacies for Weight Loss Drugs
02:17 • 5min
The Risks of Compounding Pharmacies
06:49 • 4min
The Intersection of Pharmacy and Financial Incentives
10:52 • 2min
The Telehealth Boom and GLP-1 Medications
13:11 • 7min
Ensuring Safe Use of Compounded Medications
20:38 • 3min